IDHWT GBM

Clinical trials for IDHWT GBM explained in plain language.

Never miss a new study

Get alerted when new IDHWT GBM trials appear

Sign up with your email to follow new studies for IDHWT GBM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for aggressive brain tumors: experimental combo targets first recurrence

Disease control Not yet recruiting

This early-phase trial tests a new drug (STAR-001) combined with spironolactone in about 68 adults whose glioblastoma has returned after initial treatment. The goal is to see if the combination is safe and can shrink tumors. Participants receive STAR-001 by IV twice per cycle and…

Matched conditions: IDHWT GBM

Phase: PHASE1, PHASE2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control

Last updated May 22, 2026 14:02 UTC

IDHWT GBM

Get alerted when new IDHWT GBM trials appear

New hope for aggressive brain tumors: experimental combo targets first recurrence